SCHEMBL7692003

SCHEMBL7692003

Cc1ccc(Cl)cc1Nc1nc2cc3ccccc3cc2nc1-c1cccs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 6/20 0.53
PGK1 P00558 1/20 0.44
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
POLB P06746 2/20 0.44
LMNA P02545 4/20 0.43
MAPT P10636 4/20 0.43
GAA P10253 3/20 0.43
KDM4E B2RXH2 3/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NPC1 O15118 1/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
RAB9A P51151 1/20 0.40
SRPK1 Q96SB4 1/20 0.39
GRM4 Q14833 1/20 0.38
APAF1 O14727 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PPP1CA P62136 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690215 0.82 RPS6KB2 (0.60) RPS6KB2PGK1MEN1KMT2APOLB
SCHEMBL7697783 0.80 RPS6KB2 (0.57) RPS6KB2PGK1MEN1KMT2APOLB
SCHEMBL7697776 0.77 RPS6KB2 (0.53) RPS6KB2PGK1MEN1KMT2ALMNA
SCHEMBL7697753 0.77 RPS6KB2 (0.60) RPS6KB2PGK1MEN1KMT2ALMNA
SCHEMBL7696289 0.74 KMT2A (0.58) RPS6KB2PGK1MEN1KMT2ALMNA
SCHEMBL6237808 0.73 KMT2A (0.49) RPS6KB2PGK1MEN1KMT2APOLB
SCHEMBL6235369 0.72 MEN1 (0.58) RPS6KB2PGK1MEN1KMT2APOLB
SCHEMBL7695652 0.72 RPS6KB2 (0.60) RPS6KB2PGK1MEN1KMT2APOLB
SCHEMBL7692571 0.72 RPS6KB2 (1.00) RPS6KB2MEN1KMT2ALMNAMAPT
SCHEMBL7696744 0.72 RPS6KB2 (0.77) RPS6KB2PGK1LMNAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed